Botulinum Toxin Injection Into Epicardial Fat Pads to Prevent Atrial Fibrillation in Patients Undergoing Cardiac Surgery

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 170 participants.

Also called NCT02617069

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 2/3
Enrolled
  • 170 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02617069
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Russia (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02617069. Randomized; double masking; primary purpose treatment. Start 2015-09 (registry gives no type); primary completion 2016-03 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Botulinum Toxin Injection Into Epicardial Fat Pads to Prevent Atrial Fibrillation in Patients Undergoing Cardiac Surgery
Intervention (Biological)
botulinum toxin injection
Intervention (Biological)
0.9% normal saline injection
Intervention (Device)
Implantable loop recorder
Lead sponsor
Meshalkin Research Institute of Pathology of Circulation (class: research network)

Record details

Record id
cardio:ct-nct02617069
Content hash
9e1f2a2ae647be17c08e2239fc3cf7bf6457d2396bb2276ae819c11d09973cec